DENTSPLY SIRONA (NASDAQ:XRAY) Given New $12.00 Price Target at JPMorgan Chase & Co.

DENTSPLY SIRONA (NASDAQ:XRAY) had its price target reduced by JPMorgan Chase & Co. from $14.00 to $12.00 in a report released on Friday morning,Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

XRAY has been the subject of several other reports. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research note on Friday, September 26th. Wall Street Zen lowered shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research report on Saturday, October 18th. Wells Fargo & Company decreased their price target on shares of DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating for the company in a report on Friday. Stifel Nicolaus set a $13.00 price objective on shares of DENTSPLY SIRONA in a research note on Thursday. Finally, Barrington Research reissued an “outperform” rating and set a $18.00 target price on shares of DENTSPLY SIRONA in a research note on Wednesday, October 29th. Two research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $16.42.

DENTSPLY SIRONA Price Performance

Shares of XRAY traded up $0.16 during trading hours on Friday, hitting $11.18. 6,022,111 shares of the company were exchanged, compared to its average volume of 3,066,050. The company has a debt-to-equity ratio of 1.13, a current ratio of 1.69 and a quick ratio of 1.11. The company has a market capitalization of $2.23 billion, a PE ratio of -2.36, a PEG ratio of 0.81 and a beta of 1.00. The firm has a fifty day simple moving average of $12.98 and a 200-day simple moving average of $14.47. DENTSPLY SIRONA has a one year low of $10.69 and a one year high of $20.59.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings data on Thursday, November 6th. The medical instruments supplier reported $0.37 earnings per share for the quarter, missing the consensus estimate of $0.45 by ($0.08). The firm had revenue of $904.00 million for the quarter, compared to analysts’ expectations of $900.33 million. DENTSPLY SIRONA had a positive return on equity of 16.33% and a negative net margin of 25.85%.The company’s revenue for the quarter was down 4.9% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.50 earnings per share. DENTSPLY SIRONA has set its FY 2025 guidance at 1.600-1.600 EPS. As a group, sell-side analysts predict that DENTSPLY SIRONA will post 1.84 earnings per share for the current year.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors and hedge funds have recently modified their holdings of XRAY. Syon Capital LLC bought a new stake in DENTSPLY SIRONA in the third quarter worth $199,000. Rothschild Investment LLC boosted its stake in shares of DENTSPLY SIRONA by 9,790.7% during the 3rd quarter. Rothschild Investment LLC now owns 14,836 shares of the medical instruments supplier’s stock worth $188,000 after acquiring an additional 14,686 shares in the last quarter. Vanguard Group Inc. increased its holdings in shares of DENTSPLY SIRONA by 4.1% during the 3rd quarter. Vanguard Group Inc. now owns 22,006,576 shares of the medical instruments supplier’s stock valued at $279,263,000 after acquiring an additional 869,566 shares during the last quarter. State of New Jersey Common Pension Fund D increased its holdings in shares of DENTSPLY SIRONA by 28.8% during the 3rd quarter. State of New Jersey Common Pension Fund D now owns 153,026 shares of the medical instruments supplier’s stock valued at $1,942,000 after acquiring an additional 34,197 shares during the last quarter. Finally, Caprock Group LLC bought a new position in shares of DENTSPLY SIRONA in the 3rd quarter valued at approximately $766,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.